These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
391 related items for PubMed ID: 22936790
1. N-myc and noncoding RNAs in neuroblastoma. Buechner J, Einvik C. Mol Cancer Res; 2012 Oct; 10(10):1243-53. PubMed ID: 22936790 [Abstract] [Full Text] [Related]
2. Inhibition of mir-21, which is up-regulated during MYCN knockdown-mediated differentiation, does not prevent differentiation of neuroblastoma cells. Buechner J, Henriksen JR, Haug BH, Tømte E, Flaegstad T, Einvik C. Differentiation; 2011 Jan; 81(1):25-34. PubMed ID: 20980091 [Abstract] [Full Text] [Related]
3. Distinct transcriptional MYCN/c-MYC activities are associated with spontaneous regression or malignant progression in neuroblastomas. Westermann F, Muth D, Benner A, Bauer T, Henrich KO, Oberthuer A, Brors B, Beissbarth T, Vandesompele J, Pattyn F, Hero B, König R, Fischer M, Schwab M. Genome Biol; 2008 Oct 13; 9(10):R150. PubMed ID: 18851746 [Abstract] [Full Text] [Related]
4. Next-generation RNA sequencing reveals differential expression of MYCN target genes and suggests the mTOR pathway as a promising therapy target in MYCN-amplified neuroblastoma. Schramm A, Köster J, Marschall T, Martin M, Schwermer M, Fielitz K, Büchel G, Barann M, Esser D, Rosenstiel P, Rahmann S, Eggert A, Schulte JH. Int J Cancer; 2013 Feb 01; 132(3):E106-15. PubMed ID: 22907398 [Abstract] [Full Text] [Related]
5. Inhibition of N-myc expression and induction of apoptosis by iron chelation in human neuroblastoma cells. Fan L, Iyer J, Zhu S, Frick KK, Wada RK, Eskenazi AE, Berg PE, Ikegaki N, Kennett RH, Frantz CN. Cancer Res; 2001 Feb 01; 61(3):1073-9. PubMed ID: 11221835 [Abstract] [Full Text] [Related]
6. Disruption of cooperation between Ras and MycN in human neuroblastoma cells promotes growth arrest. Yaari S, Jacob-Hirsch J, Amariglio N, Haklai R, Rechavi G, Kloog Y. Clin Cancer Res; 2005 Jun 15; 11(12):4321-30. PubMed ID: 15958613 [Abstract] [Full Text] [Related]
9. Cell lineage and differentiation state are primary determinants of MYCN gene expression and malignant potential in human neuroblastoma cells. Spengler BA, Lazarova DL, Ross RA, Biedler JL. Oncol Res; 1997 Jun 15; 9(9):467-76. PubMed ID: 9495452 [Abstract] [Full Text] [Related]
11. Expression of the apoptosis-suppressing protein bcl-2, in neuroblastoma is associated with unfavorable histology and N-myc amplification. Castle VP, Heidelberger KP, Bromberg J, Ou X, Dole M, Nuñez G. Am J Pathol; 1993 Dec 15; 143(6):1543-50. PubMed ID: 8256847 [Abstract] [Full Text] [Related]
12. Tumour-suppressor microRNAs let-7 and mir-101 target the proto-oncogene MYCN and inhibit cell proliferation in MYCN-amplified neuroblastoma. Buechner J, Tømte E, Haug BH, Henriksen JR, Løkke C, Flægstad T, Einvik C. Br J Cancer; 2011 Jul 12; 105(2):296-303. PubMed ID: 21654684 [Abstract] [Full Text] [Related]
13. Effects of a novel long noncoding RNA, lncUSMycN, on N-Myc expression and neuroblastoma progression. Liu PY, Erriquez D, Marshall GM, Tee AE, Polly P, Wong M, Liu B, Bell JL, Zhang XD, Milazzo G, Cheung BB, Fox A, Swarbrick A, Hüttelmaier S, Kavallaris M, Perini G, Mattick JS, Dinger ME, Liu T. J Natl Cancer Inst; 2014 Jul 12; 106(7):. PubMed ID: 24906397 [Abstract] [Full Text] [Related]
15. MYCN downregulates integrin alpha1 to promote invasion of human neuroblastoma cells. Tanaka N, Fukuzawa M. Int J Oncol; 2008 Oct 12; 33(4):815-21. PubMed ID: 18813796 [Abstract] [Full Text] [Related]
20. N-myc augments death and attenuates protective effects of Bcl-2 in trophically stressed neuroblastoma cells. Ushmorov A, Hogarty MD, Liu X, Knauss H, Debatin KM, Beltinger C. Oncogene; 2008 May 29; 27(24):3424-34. PubMed ID: 18193081 [Abstract] [Full Text] [Related] Page: [Next] [New Search]